High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility study.

av Jonkhoff, A. R., Plaizier, M. A., Ossenkoppele, G. J., Teule, G. J., Huijgens, P. C.
Publicerad 1995

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

av Berge, R., Oudejans, J., Ossenkoppele, G., Pulford, K., Willemze, R., Falini, B., Chott, A., Meijer, C.
Publicerad 2000

Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.

av Noorduyn, L A, de Bruin, P C, van Heerde, P, van de Sandt, M M, Ossenkoppele, G J, Meijer, C J
Publicerad 1994

Gallium-67 radiotoxicity in human U937 lymphoma cells.

av Jonkhoff, A. R., Huijgens, P. C., Versteegh, R. T., van Dieren, E. B., Ossenkoppele, G. J., Martens, H. J., Teule, G. J.
Publicerad 1993

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

av van der Poel, M. W. M., Mulder, W. J., Ossenkoppele, G. J., Maartense, E., Hoogendoorn, M., Wijermans, P., Schouten, H. C.
I publikationen Ann Hematol (2015)

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

av Huijgens, P C, Simoons-Smit, A M, van Loenen, A C, Prooy, E, van Tinteren, H, Ossenkoppele, G J, Jonkhoff, A R
Publicerad 1999

Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.

av Kiburg, B., van de Loosdrecht, A. A., Schweitzer, K. M., Ossenkoppele, G. J., Müller, L. J., Heimans, J. J., Huijgens, P. C.
Publicerad 1994

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

av Laukkanen, S, Grönroos, T, Pölönen, P, Kuusanmäki, H, Mehtonen, J, Cloos, J, Ossenkoppele, G, Gjertsen, B, Øystein, B, Heckman, C, Heinäniemi, M, Kontro, M, Lohi, O
I publikationen Blood Cancer J (2017)

Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.

av Oudejans, J. J., Kummer, J. A., Jiwa, M., van der Valk, P., Ossenkoppele, G. J., Kluin, P. M., Kluin-Nelemans, J. C., Meijer, C. J.
Publicerad 1996

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors

av Thijsen, S F T, Schuurhuis, G J, Oostveen, J W van, Theijsmeijer, A P, van der Hem, K G, Odding, J H, Dräger, A M, Ossenkoppele, G J
Publicerad 1999

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the...

av Russell, Nigel, Douglas, Kenny, Ho, Anthony D., Mohty, Mohamad, Carlson, Kristina, Ossenkoppele, G.J., Milone, Giuseppe, Pareja, Macarena Ortiz, Shaheen, Daniel, Willemsen, Arnold, Whitaker, Nicky, Chabannon, Christian
Publicerad 2013

IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival

av Verhagen, H JMP, de Leeuw, D C, Roemer, M GM, Denkers, F, Pouwels, W, Rutten, A, Celie, P H, Ossenkoppele, G J, Schuurhuis, G J, Smit, L
I publikationen Cell Death Dis (2014)

A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.

av Dukers, D F, ten Berge, R L, Oudejans, J J, Pulford, K, Hayes, D, Miseré, J F, Ossenkoppele, G J, Jaspars, L H, Willemze, R, Meijer, C J
Publicerad 1999

Hypermethylation of the FANCC and FANCL Promoter Regions in Sporadic Acute Leukaemia

av Hess, C. J., Ameziane, N., Schuurhuis, G. J., Errami, A., Denkers, F., Kaspers, G. J. L., Cloos, J., Joenje, H., Reinhardt, D., Ossenkoppele, G. J., Zwaan, C. M., Waisfisz, Q.
I publikationen Cell Oncol (2008)

CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation

av Stam, A G M, Santegoets, S J A M, Westers, T M, Sombroek, C C, Janssen, J J W M, Tillman, B W, Loosdrecht, A A van de, Pinedo, H M, Curiel, D T, Ossenkoppele, G J, Scheper, R J, de Gruijl, T D
Publicerad 2003

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

av Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J.
I publikationen Ann Hematol (2006)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

av Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
I publikationen Leukemia (2016)